Form 4 Filing: Warren Eric Sells $308K of $MLYS

INSIDER SALE

⚡ MATERIALITY: 5/10

corporate issuer

Mineralys Therapeutics, Inc.

Ticker: $MLYS

Transaction Value

$308K

Price/Share: $20.68

transaction date

2026-09-21

Shares: 14,876

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Warren Eric, holds the title of Chief Commercial Officer at Mineralys Therapeutics, Inc..

On 2026-09-21, the insider transacted 14,876 shares.The shares were transacted at a weighted average price of $20.68 per share, resulting in a total market-relevant value of $308K.

Executive Summary Summary

Warren Eric (Chief Commercial Officer) sold $308K of $MLYS

Post-Transaction Position: 38,400 shares

SEC Accession No: 0001916048-26-000014 (CIK: 1916048)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$MLYS Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$MLYS News Coverage